The new whole-body magnetic resonance imaging (MRI) platform reportedly offers enhanced image quality and increased patient comfort.
Offering an array of advanced technologies, a newly FDA-approved magnetic resonance imaging (MRI) system may provide radiologists benefits across a variety of clinical applications.
Esaote North America said the Magnifico Open MRI device features metal artifact reduction (MAR), which can facilitate postoperative imaging for patients with metal implants. The system reportedly has a low level of susceptibility for metal in comparison to traditional MRI platforms, according to the company.
When it comes to sports-related injuries, Esaote North America noted the Magnifico Open MRI also has a “True-Motion” feature that allows for real-time imaging of a joint, according to the manufacturer.
In terms of image quality, the company said the Magnifico Open MRI has a high signal-to-noise ratio (SNR) and signal homogeneity that facilitate high spatial resolution.
Emphasizing patient comfort, the open platform may ease anxiety for children and patients with claustrophobia. Esoate North American also noted the device has a transparent head coil and laser alignment that enhance patient comfort and positioning.
“The Magnifico™ Open MRI is designed for patient comfort,” said Stephen Gibbs, the manager of MRI sales and marketing for Esaote North America. “With an open-gantry design, it is ideal for imaging children, large and claustrophobic patients. The compact size is uniquely suited for hospitals, imaging centers, and in-office clinics.”
Enhancing Lesions on Breast MRI: Can an Updated Kaiser Scoring Model Improve Detection?
September 26th 2024The addition of parameters such as patient age, MIP sign and associated imaging features to the Kaiser score demonstrated a 95.6 percent AUC for breast cancer detection of enhancing lesions on breast MRI in recently published research.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.